Global Morgellons Disease Market, By Symptoms (Intense Itching, Crawling Sensations Under The Skin, Spontaneously–Appearing, Slow-Healing Lesions, Seed-Like Objects/ Granules And Black Specks On/In Skin, “Fuzz Balls” On/In Intact Skin, Fine, Thread Like Colored Fibers Beneath Or Extruding From The Skin, Life Altering Fatigue, Neurological Impairment, Visual And Hearing Changes, Brain Fog and Diminished Higher Cognitive Abilities, Hair Loss Gastrointestinal Changes, Muscle Aches, Joint Pain, General Malaise, Dental Deterioration, Sleep Disturbances, Psychiatric Manifestations, Difficulty Concentrating, Short-Term Memory Loss), Treatment (Olanzapine, Pimozide), Route of Administration (Oral, Intravenous), End-Users (Hospitals, Homecare, Speciality Centres, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2030.
Morgellons Disease Market Analysis and Size
Morgellons disease is an uncommon disorder that usually affects middle-aged white women. A number of cases occurred in California, which provoked the CDC to perform a research study to define if the cases were somehow related. Furthermore, another study in Londonreviewed five years of cases, from 2003 to 2008, and witnessed that 18 patients with a diagnosis of mysterious dermopathy or Morgellons. Out of these, 83 % were middle-aged women and 69 % were white.
Data Bridge Market Research analyses a growth rate in the morgellons disease market in the forecast period 2023-2030. The expected CAGR of the morgellons disease market tends to be around 6.60% in the mentioned forecast period. The market was valued at USD 500 million in 2022, and it would grow up to USD 833.73 million by 2030. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Morgellons Disease Market Scope and Segmentation
Report Metric |
Details |
Forecast Period |
2023 to 2030 |
Base Year |
2022 |
Historic Years |
2021 (Customizable to 2015 - 2020) |
Quantitative Units |
Revenue in USD Million, Volumes in Units, Pricing in USD |
Segments Covered |
Symptoms (Intense Itching, Crawling Sensations Under The Skin, Spontaneously–Appearing, Slow-Healing Lesions, Seed-Like Objects/ Granules And Black Specks On/In Skin, “Fuzz Balls” On/In Intact Skin, Fine, Thread Like Colored Fibers Beneath Or Extruding From The Skin, Life Altering Fatigue, Neurological Impairment, Visual And Hearing Changes, Brain Fog and Diminished Higher Cognitive Abilities, Hair Loss Gastrointestinal Changes, Muscle Aches, Joint Pain, General Malaise, Dental Deterioration, Sleep Disturbances, Psychiatric Manifestations, Difficulty Concentrating, Short-Term Memory Loss), Treatment (Olanzapine, Pimozide), Route of Administration (Oral, Intravenous), End-Users (Hospitals, Homecare, Speciality Centres, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) |
Countries Covered |
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America |
Market Players Covered |
Taj Pharmaceuticals Limited (U.S.), Lilly (U.S.), Dr. Reddy’s Laboratories Ltd (India), Anant Pharmaceuticals Pvt. Ltd (India), and Vasudha Pharma (India) |
Market Opportunities |
|
Market Definition
Morgellons disease is a type of rare, controversial, skin disorder. People having this condition experience a sensation of crawling, biting, and stinging on and in their skin. Some medical experts state that Morgellons is a physical infection or diseases. Whereas, others experts suggest it is a type of psychosis called "delusional parasitosis," wherein patient may feel like something is crawling, biting, or stinging all over and it feels like parasites have infected their skin.
Global Morgellons Disease Market Dynamics
Drivers
- Rise in Skin Infections
The occurrence of skin infections has been witnessed globally, such as tinea capitis (1-19.7%), pyoderma (prevalence range 0.2-35%), scabies (0.2-24%), viral skin disorders (0.4-9%, mostly molluscum contagiosum), pediculosis capitis (0-57%). This boosts the growth of the market.
Opportunities
- Increasing Demand for Retail Pharmacies
The increase in the number of morgellons disease therapeutics delivered through retail pharmacies and the surge in the number of retail pharmacies in highly developed countries create opportunities for market growth. Furthermore, patients choose retail pharmacies for purchasing drugs, as these are easily reachable.
Restraints/Challenges
- Lack of Skilled Professionals
A lack of trained healthcare professionals who are ignorant of the treatment methods for this disease could restrict the growth of the morgellons disease market during the forecast period.
- High Cost
The huge expenditure on the treatment methods, such as different surgical procedures and home remedies, impede the market growth.
This morgellons disease market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the morgellons disease market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Morgellons Disease Market Scope
The morgellons disease market is segmented on the basis of symptoms, treatment, route of administration, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Symptoms
- Intense Itching
- Crawling Sensations Under The Skin
- Spontaneously–Appearing, Slow-Healing Lesions
- Seed-Like Objects/ Granules And Black Specks On/In Skin
- “Fuzz Balls” On/In Intact Skin
- Fine, Thread Like Colored Fibers Beneath Or Extruding From The Skin
- Life Altering Fatigue
- Neurological Impairment
- Visual And Hearing Changes
- Brain Fog and Diminished Higher Cognitive Abilities
- Hair Loss Gastrointestinal Changes
- Muscle Aches
- Joint Pain
- General Malaise
- Dental Deterioration
- Sleep Disturbances
- Psychiatric Manifestations
- Difficulty Concentrating
- Short-Term Memory Loss
Treatment
- Olanzapine
- Pimozide
Route of Administration
- Oral
- Intravenous
End-Users
- Hospitals
- Homecare
- Speciality Centres
- Others
Distribution Channel
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
Morgellons Disease Market Regional Analysis/Insights
The morgellons disease market is analyzed and market size insights and trends are provided by symptoms, treatment, route of administration, distribution channel and end-user as referenced above.
The major countries covered in the morgellons disease market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America is expected to have the highest market growth due to the presence of well developed healthcare infrastructure and favorable government support.
Asia-Pacific dominates the market due to the rise in the healthcare per capita expenditure and the increase in the awareness.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Global Morgellons Disease Market Share Analysis
The morgellons disease market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to morgellons disease market.
Key players operating in the morgellons disease market include:
- Taj Pharmaceuticals Limited (U.S.)
- Lilly (U.S.)
- Dr. Reddy’s Laboratories Ltd.(India)
- Anant Pharmaceuticals Pvt. Ltd (India)
- Vasudha Pharma (India)
SKU-